Pfizer is betting big on cancer drugs to turn business around after Covid decline – here’s what to know
The pharmaceutical giant has been trying to shore up investor sentiment after its shares fell more than 40% in 2023.
Read MoreThe pharmaceutical giant has been trying to shore up investor sentiment after its shares fell more than 40% in 2023.
Read MoreLars Fruergaard Jørgensen's remarks came one day after Novo Nordisk impressed investors with early-stage trial data on amycretin. Source link
Read MoreThe FDA plans to call a last-minute meeting of its outside advisors to further review the Eli Lilly Alzheimer's treatment's
Read MoreWegovy obesity drug maker Novo Nordisk surpassed Tesla in market value Thursday after fresh early trial data showed positive results
Read MoreSome Wall Street analysts said Viking's experimental obesity treatment may be "best-in-class" following the release of midstage trial data. Source
Read MoreCVS and Walgreens have received certification from the FDA to dispense the commonly used mifepristone at their retail pharmacies, spokespeople
Read MoreBreakthrough sickle cell treatments are available in the U.S., but their high cost is forcing insurers to get creative. Source
Read MoreThe total amount Novavax will pay depends on whether Gavi decides to order more Covid shots from the cash-strapped company
Read MoreThe rollout of Alzheimer's treatment Leqembi from Biogen is going slower than expected, providing a read-through for Club stock Eli
Read More